Model DetailsProstate gland carcinoma - neuroendocrine
Model Name |
Prostate gland carcinoma - neuroendocrine | Strain |
(C57BL/6J x NOD/LtJ)F1-Tg(TRAMP)8247Ng |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
prostate cancer • prostatic tumor • NE tumor • prostate neuroendocrine (NE) carcinoma • prostate tumor • neuroendocrine prostate tumor • NE carcinoma • prostate neuroendocrine (NE) phenotype tumor • prostate carcinoma • NE lesion / tumor |
Strain Synonyms |
C57BL/6-Tg(TRAMP)8247Ng/J x NOD/LtJ F1 • TRAMP x NOD/LtJ F1 • PB-TAg • TRAMP-NOD • TRAMP F1 |
Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
---|---|---|---|---|---|
Prostate gland | Male |
>=95 |
|
Patel SJ, PLoS One 2013;8(4):e61848 | |
Kidney | Male |
29% (12 of 42 mice) |
|
Patel SJ, PLoS One 2013;8(4):e61848 | |
Liver | Male |
26% (11 of 42 mice) |
|
Patel SJ, PLoS One 2013;8(4):e61848 | |
Liver | Male |
29% (12 of 42 mice) |
|
Patel SJ, PLoS One 2013;8(4):e61848 | |
Lung | Male |
76% (22 of 29 mice) |
|
Patel SJ, PLoS One 2013;8(4):e61848 | |
Lymph node | Male |
95% (40 of 42 mice) |
|
Patel SJ, PLoS One 2013;8(4):e61848 | |
Prostate gland | Male |
33% (1 of 3 mice) |
8 weeks |
|
Patel SJ, PLoS One 2013;8(4):e61848 |
Prostate gland | Male |
67% (2 of 3 mice) |
12 weeks |
|
Patel SJ, PLoS One 2013;8(4):e61848 |
Prostate gland | Male |
100% (3 of 3 mice) |
16 weeks |
|
Patel SJ, PLoS One 2013;8(4):e61848 |
Prostate gland | Male |
100% (3 of 3 mice) |
20 weeks |
|
Patel SJ, PLoS One 2013;8(4):e61848 |